UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF ILLINOIS
January 2, 2013
IN RE: PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION
The opinion of the court was delivered by: David R. Herndon Chief Judge United States District Court
This Document Relates to:
THELMA BUTNER, CLIFTON FITZSIMMONS, JOHN WILCHINSKI, GEORGE FLETCHER, and PAULINE Case No. 3:12-cv-60092-DRH-SCW ALDRIDGE, Plaintiffs, v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., et al., Defendants.
ORDER SETTING BRIEFING SCHEDULE FOR PENDING MOTIONS AND RESPONSIVE PLEADINGS
The Court hereby issues the following Order relating to the above-referenced action, which was transferred to MDL 2385 by the Judicial Panel on Multidistrict Litigation on December 7, 2012.
x Response by Boehringer Ingelheim Pharmaceuticals, Inc. ("BIPI") to Plaintiffs' Motion to Remand to be filed by January 2, 2013. Plaintiffs' Reply, if any, to be filed by January 16, 2013.
Further Responsive Pleadings:
x Deadlines to respond to all other pleadings in this action are stayed pending a ruling on the Plaintiff's Motion to Remand.
Digitally signed by
Date: 2013.01.02 11:10:13 -06'00'
© 1992-2013 VersusLaw Inc.